Skip to main content
Livermore
Livermore
ZHEN

Virtus Fund Advisers, LLC

SEC CIK
0001319111
Latest filing
Feb 14, 2025

HALO holding history

Halozyme Therapeutics, Inc. in every 13F filed by Virtus Fund Advisers, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HALO overviewAll 13F holders of HALOFull Q4 2024 holdings

Shares (Q4 2024)
436
Value
$20.8K
% of portfolio
0.1%
Quarters held
9
Since Q4 2022
Holdings of HALO by Virtus Fund Advisers, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 2024436$20.8K0.1%−321−42.4%ReducedHolders
Q3 2024757$43.3K0.2%00.0%UnchangedHolders
Q2 2024757$39.6K0.2%+7+0.9%AddedHolders
Q1 2024750$30.5K0.1%00.0%UnchangedHolders
Q4 2023750$27.7K0.2%00.0%UnchangedHolders
Q3 2023750$28.6K0.2%00.0%UnchangedHolders
Q2 2023750$27.1K0.2%00.0%UnchangedHolders
Q1 2023750$28.6K0.2%00.0%UnchangedHolders
Q4 2022750$42.7K0.3%+750NewHolders